A STUDY OF TOFACITINIB FOR THE TREATMENT OF REFRACTORY IMMUNE-RELATED COLITIS FROM CHECKPOINT INHIBITOR THERAPY

Registry ID

TRICK-01

Source registry

HEALTH_CANADA

Status

Closed

Study type

INTERVENTIONAL

Sponsor

JEWISH GENERAL HOSPITAL

Start date

2021-10-12

Completion date

2024-01-17

Last update

2021-03-10

Conditions

• IMMUNE-RELATED COLITIS

Related clinical trials

• A PHASE I STUDY OF KAN-004 IN PATIENTS WITH IMMUNE-RELATED DIARRHEA OR COLITIS
• PROPHYLACTIC ORAL MESALAMINE FOR THE PREVENTION OF IMMUNE-RELATED COLITIS IN PATIENTS TREATED WITH IPILIMUMAB/NIVOLUMAB

View on source registry